160 related articles for article (PubMed ID: 18663360)
21. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription.
Ju BG; Lunyak VV; Perissi V; Garcia-Bassets I; Rose DW; Glass CK; Rosenfeld MG
Science; 2006 Jun; 312(5781):1798-802. PubMed ID: 16794079
[TBL] [Abstract][Full Text] [Related]
22. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
Bai Y; Giguére V
Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
[TBL] [Abstract][Full Text] [Related]
23. Poly(ADP-ribose) polymerase-1 modulates Nrf2-dependent transcription.
Wu T; Wang XJ; Tian W; Jaramillo MC; Lau A; Zhang DD
Free Radic Biol Med; 2014 Feb; 67():69-80. PubMed ID: 24140708
[TBL] [Abstract][Full Text] [Related]
24. Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage.
Lim JH; Kim KM; Kim SW; Hwang O; Choi HJ
Pharmacol Res; 2008 May; 57(5):325-31. PubMed ID: 18455424
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells.
Dhakshinamoorthy S; Porter AG
J Biol Chem; 2004 May; 279(19):20096-107. PubMed ID: 14985350
[TBL] [Abstract][Full Text] [Related]
26. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
27. 17β-Estradiol regulates oxidative stress in prostate cancer cell lines according to ERalpha/ERbeta ratio.
Miró AM; Sastre-Serra J; Pons DG; Valle A; Roca P; Oliver J
J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):133-9. PubMed ID: 21172438
[TBL] [Abstract][Full Text] [Related]
28. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
29. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction.
Ma Q; Kinneer K; Bi Y; Chan JY; Kan YW
Biochem J; 2004 Jan; 377(Pt 1):205-13. PubMed ID: 14510636
[TBL] [Abstract][Full Text] [Related]
30. The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells.
Lo R; Matthews J
Toxicol Appl Pharmacol; 2013 Jul; 270(2):139-48. PubMed ID: 23583297
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
van de Stolpe A; Slycke AJ; Reinders MO; Zomer AW; Goodenough S; Behl C; Seasholtz AF; van der Saag PT
Mol Endocrinol; 2004 Dec; 18(12):2908-23. PubMed ID: 15345745
[TBL] [Abstract][Full Text] [Related]
33. Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity.
Ramaswamy B; Majumder S; Roy S; Ghoshal K; Kutay H; Datta J; Younes M; Shapiro CL; Motiwala T; Jacob ST
Mol Endocrinol; 2009 Feb; 23(2):176-87. PubMed ID: 19095770
[TBL] [Abstract][Full Text] [Related]
34. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection.
Dreger H; Westphal K; Weller A; Baumann G; Stangl V; Meiners S; Stangl K
Cardiovasc Res; 2009 Jul; 83(2):354-61. PubMed ID: 19351736
[TBL] [Abstract][Full Text] [Related]
35. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the induction of DNA strand breaks and poly(ADP-ribose) polymerase-1 activation by 17beta-estradiol in human breast carcinoma cells through alteration of CYP1A1 and CYP1B1 expression.
Lin PH; Lin CH; Huang CC; Fang JP; Chuang MC
Chem Res Toxicol; 2008 Jul; 21(7):1337-47. PubMed ID: 18558727
[TBL] [Abstract][Full Text] [Related]
36. Promoter cleavage: a topoIIbeta and PARP-1 collaboration.
Lis JT; Kraus WL
Cell; 2006 Jun; 125(7):1225-7. PubMed ID: 16814707
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen increases nuclear respiratory factor 1 transcription by activating estrogen receptor beta and AP-1 recruitment to adjacent promoter binding sites.
Ivanova MM; Luken KH; Zimmer AS; Lenzo FL; Smith RJ; Arteel MW; Kollenberg TJ; Mattingly KA; Klinge CM
FASEB J; 2011 Apr; 25(4):1402-16. PubMed ID: 21233487
[TBL] [Abstract][Full Text] [Related]
38. Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells.
Lin CH; Lin PH
Chem Biol Interact; 2006 Aug; 162(2):181-94. PubMed ID: 16884709
[TBL] [Abstract][Full Text] [Related]
39. Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
Mishra AK; Abrahamsson A; Dabrosin C
Oncotarget; 2016 Aug; 7(35):56876-56888. PubMed ID: 27486755
[TBL] [Abstract][Full Text] [Related]
40. The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol.
Nadal-Serrano M; Sastre-Serra J; Pons DG; Miró AM; Oliver J; Roca P
J Cell Biochem; 2012 Oct; 113(10):3178-85. PubMed ID: 22615145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]